Low-dose belantamab mafodotin (belamaf) in combination with nirogacestat vs belamaf monotherapy in patients with relapsed/refractory multiple myeloma (RRMM): phase I/II DREAMM-5 platform sub-study 3

被引：0

作者：

Leypoldt, L. ^{[1
]}

Callander, N. S. ^{[2
]}

Richardson, P. G. ^{[3
]}

Hus, M. ^{[4
]}

Ribrag, V. ^{[5
]}

Lopez, J. M. ^{[6
]}

Kim, K. ^{[7
]}

Lee, J. H. ^{[8
]}

Dimopoulos, M. A. ^{[9
,10
]}

Schjesvold, F. ^{[11
,12
]}

Facon, T. ^{[13
]}

Jo, J. -C. ^{[14
]}

Min, C. -K. ^{[15
]}

Mielnik, M. ^{[4
]}

Cheng, S. ^{[16
]}

Smith, L. M. ^{[16
]}

Breitbach, C. J. ^{[16
]}

Brawley, C. ^{[17
]}

Sembhi, H. ^{[17
]}

LaMacchia, J. ^{[18
]}

Grosicki, S. ^{[19
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[2] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Katedra & Klin Hematoonkol & Transplantacji Szpik, Lublin, Poland

[5] Inst Gustave Roussy, Villejuif, France

[6] Univ Complutense Madrid, Hosp Univ 12 Octubre, Dept Hematol, CNIO,CIBERONC, Madrid, Spain

[7] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[8] Gachon Univ, Gachon Univ Gil Med Ctr, Coll Med, Incheon, South Korea

[9] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece

[10] Alexandra Hosp, Athens, Greece

[11] Oslo Univ Hosp, Oslo Myeloma Ctr, Dept Hematol, Oslo, Norway

[12] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway

[13] Lille Univ Hosp, Dept Haematol, Lille, France

[14] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Ulsan, South Korea

[15] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[16] SpringWorks Therapeut, Stamford, CT USA

[17] GSK, Stevenage, Herts, England

[18] GSK, Waltham, MA USA

[19] Med Univ Silesia, Dept Hematol & Canc Prevent, Katowice, Poland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P330

引用

页码：176 / 177

页数：2